Fortitude Family Office »

Lisata Therapeutics shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Lisata Therapeutics (LSTA) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Lisata Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lisata Therapeutics held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lisata Therapeutics by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $2 1 2.00

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Apple Stock (AAPL)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Mid-cap Etf Etf (VO)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Senior Loan Etf Etf (BKLN)
Ishares Core S&p Mid-cap Etf Etf (IJH)

View all positions for Fortitude Family Office

Top funds holding Lisata Therapeutics

Vanguard Group
Renaissance Technologies
BML Capital Management
Geode Capital Management
BlackRock
Ground Swell Capital
Dimensional Fund Advisors
State Street Corporation
HPM Partners
XTX Topco
Northern Trust
HighTower Advisors
Royal Bank of Canada
Tower Research Capital
Founders Capital Management

View all funds holding Lisata Therapeutics